+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Latent TB Testing Market (2025 Edition): Analysis By Test Type (Tuberculin Skin Test (TST), and Interferon Gamma Released Assay (IGRA)), By End User, By Region, By Country: Market Insights and Forecast (2020-2030)- Product Image
Latent TB Testing Market (2025 Edition): Analysis By Test Type (Tuberculin Skin Test (TST), and Interferon Gamma Released Assay (IGRA)), By End User, By Region, By Country: Market Insights and Forecast (2020-2030)- Product Image
New

Latent TB Testing Market (2025 Edition): Analysis By Test Type (Tuberculin Skin Test (TST), and Interferon Gamma Released Assay (IGRA)), By End User, By Region, By Country: Market Insights and Forecast (2020-2030)

  • PDF Icon

    Report

  • 198 Pages
  • February 2025
  • Region: Global
  • Azoth Analytics
  • ID: 5912553
Description Jump to:
This report provides a complete analysis of the Global Latent TB Testing industry in terms of market segmentation By Test Type (Tuberculin Skin Test (TST), and Interferon Gamma Released Assay (IGRA)), By End User (Diagnostic Laboratories, Hospitals and Clinics, and Academic and Research Institute), for the historical period of 2020-2023, the estimates of 2024 and the forecast period of 2025-2030.

The Global Latent TB Testing market showcased growth at a CAGR of 10.47% during 2020-2023. The market was valued at USD 1.99 billion in 2023 which is expected to reach USD 4.43 billion in 2030. Latent TB Testing Market is being propelled by government initiatives and policies, rising awareness and education, and technological advancements in testing methods.The prevalence of TB, especially in high-burden regions, drives the need for effective latent TB testing. As TB remains a global health concern, early detection and management of latent infections become critical for disease control.

The global latent TB testing market is witnessing a surge in multiplex testing capabilities, enabling simultaneous detection of multiple biomarkers associated with latent and active TB. This innovation reduces diagnostic turnaround times and facilitates comprehensive patient management. Furthermore, advancements in molecular diagnostics, such as polymerase chain reaction (PCR)-based assays, are enabling precise detection of latent TB infections by targeting specific genomic sequences of Mycobacterium tuberculosis. These molecular techniques are especially beneficial for diagnosing latent TB in immunocompromised individuals, such as HIV/AIDS patients, where traditional methods may yield inconclusive results.

Point-of-care (POC) testing is another transformative trend gaining traction in the latent TB testing landscape. Portable and user-friendly POC devices empower healthcare providers to conduct rapid testing in remote and resource-limited settings, addressing accessibility challenges in underserved populations. These advancements are particularly crucial in low-income countries, where the burden of latent TB is disproportionately high. Moreover, the miniaturization of diagnostic platforms and the development of battery-operated devices enhance the feasibility of on-the-ground testing initiatives.

Telemedicine and remote diagnostics are reshaping the latent TB testing ecosystem, driven by the COVID-19 pandemic’s emphasis on remote healthcare delivery. Mobile health (mHealth) applications and teleconsultation platforms facilitate virtual screening, symptom monitoring, and follow-up care, reducing the need for in-person visits. This trend not only enhances patient convenience but also expands the reach of TB control programs to geographically dispersed populations.

Furthermore, the latent TB testing market is experiencing a paradigm shift towards personalized medicine, with advancements in genomics and proteomics paving the way for tailored diagnostic and therapeutic approaches. Biomarker-based tests and pharmacogenomic profiling are enabling precise risk stratification and individualized treatment plans, thereby improving patient outcomes and reducing the risk of latent TB progressing to active disease. Additionally, ongoing research into novel biomarkers and immune response pathways promises to unlock further innovations in latent TB diagnostics.

Moreover, the global latent TB testing market is undergoing a profound transformation driven by technological advancements and emerging trends. The integration of next-generation diagnostic tools, automation, AI, POC testing, multiplex capabilities, molecular diagnostics, telemedicine, and personalized medicine underscores the industry’s commitment to combating latent TB through innovative and accessible solutions. These developments not only enhance the effectiveness of latent TB control programs but also contribute to the broader goal of eradicating tuberculosis as a global public health threat.

Scope of the Report

  • The report analyses the Latent TB Testing Market by Value (USD Million).
  • The report analyses the Latent TB Testing Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, United Kingdom France, Germany, China, South Korea, Australia, Japan, and India).
  • The report presents the analysis of Latent TB Testing Market for the historical period of 2020-2023, the estimated year 2024 and the forecast period of 2025-2030.
  • The report analyses the Latent TB Testing Market by Test Type (Tuberculin Skin Test (TST), and Interferon Gamma Released Assay (IGRA)).
  • The report analyses the Latent TB Testing Market by End User (Diagnostic Laboratories, Hospitals and Clinics, and Academic and Research Institute).
  • The key insights of the report have been presented through the frameworks of SWOT and Porter’s Five Forces Analysis. Also, the attractiveness of the market has been presented by region, by test type, & by end user.
  • Also, the major opportunities, trends, drivers, and challenges of the industry has been analyzed in the report.
  • The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analyzed in the report are QIAGEN, Sanofi, Abbott Laboratories, Serum Institute of India, F. Hoffmann-La Roche AG, Bio-Rad Laboratories, PerkinElmer Inc., BioMerieux, Becton Dickinson and Co, LIONEX GmbH.

Table of Contents

1. Market Background
1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodology
2. Analyst Recommendations
2.1 Amplify the incorporation of technological advancement in diagnostic laboratories
2.2 Increase the R&D spending to improve the efficacy of testing rates
3. Global Latent TB Testing Market: Historic and Forecast
3.1 Impact Analysis of Macro Economic Factors on Global Latent TB Testing Market
3.2 Epidemiology: Global Latent TB Prevalence
3.3 Epidemiology: Global Tuberculosis Prevalence
3.4 Epidemiology: Global Tuberculosis Incidence
3.5 Global Latent TB Testing Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
3.6 Global Latent TB Testing Market Segmentation: By Test Type
3.6.1 Global Latent TB Testing Market, By Test Type Overview
3.6.2 Global Latent TB Testing Market Attractiveness Index, By Test Type
3.6.3 Global Latent TB Testing Market Size, By Tuberculin Skin Test (TST), By Value, 2020H-2030F (USD Million & CAGR)
3.6.4 Global Latent TB Testing Market Size, By Interferon Gamma Released Assay (IGRA), By Value, 2020H-2030F (USD Million & CAGR)
3.7 Global Latent TB Testing Market Segmentation: By End User
3.7.1 Global Latent TB Testing Market, By End User Overview
3.7.2 Global Latent TB Testing Market Attractiveness Index, By End User
3.7.3 Global Latent TB Testing Market Size, By Diagnostic Laboratories, By Value, 2020H-2030F (USD Million & CAGR)
3.7.4 Global Latent TB Testing Market Size, By Hospitals and Clinics, By Value, 2020H-2030F (USD Million & CAGR)
3.7.5 Global Latent TB Testing Market Size, By Academic and Research Institute, By Value, 2020H-2030F (USD Million & CAGR)
4. Latent TB Testing Market, Region Analysis
4.1 Regional Coverage of the Study
4.2 Regional Snapshot
5. Americas Latent TB Testing Market: Historic and Forecast
5.1 Americas Latent TB Testing Market: Snapshot
5.2 Americas Latent TB Testing Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.3 Americas Latent TB Testing Market: Key Factors
5.4 Americas Latent TB Testing Market: Segment Analysis
5.5 Americas Latent TB Testing Market Segmentation: By Test Type
5.5.1 Americas Latent TB Testing Market, By Test Type Overview
5.5.2 Americas Latent TB Testing Market Size, By Tuberculin Skin Test (TST), By Value, 2020H-2030F (USD Million & CAGR)
5.5.3 Americas Latent TB Testing Market Size, By Interferon Gamma Released Assay (IGRA), By Value, 2020H-2030F (USD Million & CAGR)
5.6 Americas Latent TB Testing Market Segmentation: By End User
5.6.1 Americas Latent TB Testing Market, By End User Overview
5.6.2 Americas Latent TB Testing Market Size, By Diagnostic Laboratories, By Value, 2020H-2030F (USD Million & CAGR)
5.6.3 Americas Latent TB Testing Market Size, By Hospitals and Clinics, By Value, 2020H-2030F (USD Million & CAGR)
5.6.4 Americas Latent TB Testing Market Size, By Academic and Research Institute, By Value, 2020H-2030F (USD Million & CAGR)
5.7 Americas Latent TB Testing Market Segmentation: By Country
5.7.1 Americas Latent TB Testing Market, By Country Overview
5.7.2 United States Latent TB Testing Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.7.2.1 United States Latent TB Testing Market, By Test Type
5.7.2.2 United States Latent TB Testing Market, By End User
5.7.3 Canada Latent TB Testing Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.7.3.1 Canada Latent TB Testing Market, By Test Type
5.7.3.2 Canada Latent TB Testing Market, By End User
5.7.4 Rest of Americas Latent TB Testing Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.7.4.1 Rest of Americas Latent TB Testing Market, By Test Type
5.7.4.2 Rest of Americas Latent TB Testing Market, By End User
6. Europe Latent TB Testing Market: Historic and Forecast
6.1 Europe Latent TB Testing Market: Snapshot
6.2 Europe Latent TB Testing Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.3 Europe Latent TB Testing Market: Key Factors
6.4 Europe Latent TB Testing Market: Segment Analysis
6.5 Europe Latent TB Testing Market Segmentation: By Test Type
6.5.1 Europe Latent TB Testing Market, By Test Type Overview
6.5.2 Europe Latent TB Testing Market Size, By Tuberculin Skin Test (TST), By Value, 2020H-2030F (USD Million & CAGR)
6.5.3 Europe Latent TB Testing Market Size, By Interferon Gamma Released Assay (IGRA), By Value, 2020H-2030F (USD Million & CAGR)
6.6 Europe Latent TB Testing Market Segmentation: By End User
6.6.1 Europe Latent TB Testing Market, By End User Overview
6.6.2 Europe Latent TB Testing Market Size, By Diagnostic Laboratories, By Value, 2020H-2030F (USD Million & CAGR)
6.6.3 Europe Latent TB Testing Market Size, By Hospitals and Clinics, By Value, 2020H-2030F (USD Million & CAGR)
6.6.4 Europe Latent TB Testing Market Size, By Academic and Research Institute, By Value, 2020H-2030F (USD Million & CAGR)
6.7 Europe Latent TB Testing Market Segmentation: By Country
6.7.1 Europe Latent TB Testing Market, By Country Overview
6.7.2 Germany Latent TB Testing Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.7.2.1 Germany Latent TB Testing Market, By Test Type
6.7.2.2 Germany Latent TB Testing Market, By End User
6.7.3 United Kingdom Latent TB Testing Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.7.3.1 United Kingdom Latent TB Testing Market, By Test Type
6.7.3.2 United Kingdom Latent TB Testing Market, By End User
6.7.4 France Latent TB Testing Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.7.4.1 France Latent TB Testing Market, By Test Type
6.7.4.2 France Latent TB Testing Market, By End User
6.7.5 Rest of Europe Latent TB Testing Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.7.5.1 Rest of Europe Latent TB Testing Market, By Test Type
6.7.5.2 Rest of Europe Latent TB Testing Market, By End User
7. Asia Pacific Latent TB Testing Market: Historic and Forecast
7.1 Asia Pacific Latent TB Testing Market: Snapshot
7.2 Asia Pacific Latent TB Testing Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.3 Asia Pacific Latent TB Testing Market: Key Factors
7.4 Asia Pacific Latent TB Testing Market: Segment Analysis
7.5 Asia Pacific Latent TB Testing Market Segmentation: By Test Type
7.5.1 Asia Pacific Latent TB Testing Market, By Test Type Overview
7.5.2 Asia Pacific Latent TB Testing Market Size, By Tuberculin Skin Test (TST), By Value, 2020H-2030F (USD Million & CAGR)
7.5.3 Asia Pacific Latent TB Testing Market Size, By Interferon Gamma Released Assay (IGRA), By Value, 2020H-2030F (USD Million & CAGR)
7.6 Asia Pacific Latent TB Testing Market Segmentation: By End User
7.6.1 Asia Pacific Latent TB Testing Market, By End User Overview
7.6.2 Asia Pacific Latent TB Testing Market Size, By Diagnostic Laboratories, By Value, 2020H-2030F (USD Million & CAGR)
7.6.3 Asia Pacific Latent TB Testing Market Size, By Hospitals and Clinics, By Value, 2020H-2030F (USD Million & CAGR)
7.6.4 Asia Pacific Latent TB Testing Market Size, By Academic and Research Institute, By Value, 2020H-2030F (USD Million & CAGR)
7.7 Asia Pacific Latent TB Testing Market Segmentation: By Country
7.7.1 Asia Pacific Latent TB Testing Market, By Country Overview
7.7.2 China Latent TB Testing Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.7.2.1 China Latent TB Testing Market, By Test Type
7.7.2.2 China Latent TB Testing Market, By End User
7.7.3 Japan Latent TB Testing Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.7.3.1 Japan Latent TB Testing Market, By Test Type
7.7.3.2 Japan Latent TB Testing Market, By End User
7.7.4 India Latent TB Testing Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.7.4.1 India Latent TB Testing Market, By Test Type
7.7.4.2 India Latent TB Testing Market, By End User
7.7.5 South Korea Latent TB Testing Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.7.5.1 South Korea Latent TB Testing Market, By Test Type
7.7.5.2 South Korea Latent TB Testing Market, By End User
7.7.6 Australia Latent TB Testing Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.7.6.1 Australia Latent TB Testing Market, By Test Type
7.7.6.2 Australia Latent TB Testing Market, By End User
7.7.7 Rest of Asia Pacific Latent TB Testing Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.7.7.1 Rest of Asia Pacific Latent TB Testing Market, By Test Type
7.7.7.2 Rest of Asia Pacific Latent TB Testing Market, By End User
8. Middle East & Africa Latent TB Testing Market: Historic and Forecast
8.1 Middle East and Africa Latent TB Testing Market: Snapshot
8.2 Middle East and Africa Latent TB Testing Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
8.3 Middle East and Africa Latent TB Testing Market: Key Factors
8.4 Middle East and Africa Latent TB Testing Market: Segment Analysis
8.5 Middle East and Africa Latent TB Testing Market Segmentation: By Test Type
8.5.1 Middle East and Africa Latent TB Testing Market, By Test Type Overview
8.5.2 Middle East and Africa Latent TB Testing Market Size, By Tuberculin Skin Test (TST), By Value, 2020H-2030F (USD Million & CAGR)
8.5.3 Middle East and Africa Latent TB Testing Market Size, By Interferon Gamma Released Assay (IGRA), By Value, 2020H-2030F (USD Million & CAGR)
8.6 Middle East and Africa Latent TB Testing Market Segmentation: By End User
8.6.1 Middle East and Africa Latent TB Testing Market, By End User Overview
8.6.2 Middle East and Africa Latent TB Testing Market Size, By Diagnostic Laboratories, By Value, 2020H-2030F (USD Million & CAGR)
8.6.3 Middle East and Africa Latent TB Testing Market, By Hospitals and Clinics, By Value, 2020H-2030F (USD Million & CAGR)
8.6.4 Middle East and Africa Latent TB Testing Market, By Academic and Research Institute, By Value, 2020H-2030F (USD Million & CAGR)
9. Market Dynamics
9.1 Impact assessment of Market Dynamics on Global Latent TB Testing Market
9.2 Drivers
9.3 Restraints
9.4 Trends
10. Industry Ecosystem Analysis
10.1 Porter Analysis
11. Competitive Positioning
11.1 Companies’ Product Positioning
11.2 Market Share Analysis of Latent TB Testing Market
11.3 Company Profiling
11.3.1 QIAGEN
11.3.2 Sanofi
11.3.3 Abbott Laboratories
11.3.4 F. Hoffmann-La Roche AG
11.3.5 Bio-Rad Laboratories
11.3.6 BioMerieux
11.3.7 Becton Dickinson and Co
11.3.8 Serum Institute of India
11.3.9 PerkinElmer Inc.
11.3.10 LIONEX GmbH
12. About the Publisher & Disclaimer
List of Figures
Figure 1: Global Latent TB Testing Market Size, By Value, 2020-2023 (USD Million)
Figure 2: Global Latent TB Testing Market Size, By Value, 2024-2030 (USD Million)
Figure 3: Global Latent TB Testing Market Share, By Test Type, 2023 (%)
Figure 4: Market Attractiveness Analysis of Global Latent TB Testing Market, By Test Type (2025-2030)
Figure 5: Global Latent TB Testing Market Size, By Tuberculin Skin Test (TST), By Value, 2020H-2030F (USD Million & CAGR)
Figure 6: Global Latent TB Testing Market Absolute Opportunity, By Tuberculin Skin Test (TST), 2020H-2030F (USD Million)
Figure 7: Global Latent TB Testing Market Size, By Interferon Gamma Released Assay (IGRA) , By Value, 2020H-2030F (USD Million & CAGR)
Figure 8: Global Latent TB Testing Market Absolute Opportunity, By Interferon Gamma Released Assay (IGRA) , 2020H-2030F (USD Million)
Figure 9: Market Attractiveness Analysis of Global Latent TB Testing Market, By End User (2025-2030)
Figure 10: Global Latent TB Testing Market Size, By Diagnostic Laboratories, By Value, 2020H-2030F (USD Million & CAGR)
Figure 11: Global Latent TB Testing Market Absolute Opportunity, By Diagnostic Laboratories, 2020H-2030F (USD Million)
Figure 12: Global Latent TB Testing Market Size, By Hospitals and Clinics, By Value, 2020H-2030F (USD Million & CAGR)
Figure 13: Global Latent TB Testing Market Absolute Opportunity, By Hospitals and Clinics, 2020H-2030F (USD Million)
Figure 14: Global Latent TB Testing Market Size, By Academic and Research Institute, By Value, 2020H-2030F (USD Million & CAGR)
Figure 15: Global Latent TB Testing Market Absolute Opportunity, By Academic and Research Institute, 2020H-2030F (USD Million)
Figure 16: Americas Latent TB Testing Market Size, By Value, 2020H-2030F (USD Million)
Figure 17: Americas Latent TB Testing Market Share, By Test Type, 2023 (%)
Figure 18: Americas Latent TB Testing Market, By Tuberculin Skin Test (TST), By Value, 2020H-2030F (USD Million & CAGR)
Figure 19: Americas Latent TB Testing Market, By Interferon Gamma Released Assay (IGRA), By Value, 2020H-2030F (USD Million & CAGR)
Figure 20: Americas Latent TB Testing Market, By Diagnostic Laboratories, By Value, 2020H-2030F (USD Million & CAGR)
Figure 21: Americas Latent TB Testing Market, By Hospitals and Clinics, By Value, 2020H-2030F (USD Million & CAGR)
Figure 22: Americas Latent TB Testing Market, By Academic and Research Institute, By Value, 2020H-2030F (USD Million & CAGR)
Figure 23: United States Latent TB Testing Market, By Value, 2020H-2030F (USD Million & CAGR)
Figure 24: United States Latent TB Testing Market Value, By End User, 2023 (USD Million)
Figure 25: United States Latent TB Testing Market Share, By Test Type, By Value, 2023 (%)
Figure 26: United States Latent TB Testing Market Share, By End User, By Value, 2023 (%)
Figure 27: Canada Latent TB Testing Market, By Value, 2020H-2030F (USD Million & CAGR)
Figure 28: Canada Latent TB Testing Market Value, By End User,, 2023 (USD Million)
Figure 29: Canada Latent TB Testing Market Share, By Test Type, By Value, 2023 (%)
Figure 30: Canada Latent TB Testing Market Share, By End User, By Value, 2023 (%)
Figure 31: Rest of Americas Latent TB Testing Market, By Value, 2020H-2030F (USD Million & CAGR)
Figure 32: Rest of Americas Latent TB Testing Market Value, By End User, 2023 (USD Million)
Figure 33: Rest of Americas Latent TB Testing Market Share, By Test Type, By Value, 2023 (%)
Figure 34: Rest of Americas Latent TB Testing Market Share, By End User, By Value, 2023 (%)
Figure 35: Europe Latent TB Testing Market Size, By Value, 2020H-2030F (USD Million)
Figure 36: Europe Latent TB Testing Market Share, By Test Type, 2023 (%)
Figure 37: Europe Latent TB Testing Market, By Tuberculin Skin Test (TST), By Value, 2020H-2030F (USD Million & CAGR)
Figure 38: Europe Latent TB Testing Market, By Interferon Gamma Released Assay (IGRA), By Value, 2020H-2030F (USD Million & CAGR)
Figure 39: Europe Latent TB Testing Market, By Diagnostic Laboratories, By Value, 2020H-2030F (USD Million & CAGR)
Figure 40: Europe Latent TB Testing Market, By Hospitals and Clinics, By Value, 2020H-2030F (USD Million & CAGR)
Figure 41: Europe Latent TB Testing Market, By Academic and Research Institute, By Value, 2020H-2030F (USD Million & CAGR)
Figure 42: Germany Latent TB Testing Market, By Value, 2020H-2030F (USD Million & CAGR)
Figure 43: Germany Latent TB Testing Market Value, By End User, 2023 (USD Million)
Figure 44: Germany Latent TB Testing Market Share, By Test Type, By Value, 2023 (%)
Figure 45: Germany Latent TB Testing Market Share, By End User, By Value, 2023 (%)
Figure 46: United Kingdom Latent TB Testing Market, By Value, 2020H-2030F (USD Million & CAGR)
Figure 47: United Kingdom Latent TB Testing Market Value, By End User, 2023 (USD Million)
Figure 48: United Kingdom Latent TB Testing Market Share, By Test Type, By Value, 2023 (%)
Figure 49: United Kingdom Latent TB Testing Market Share, By End User, By Value, 2023 (%)
Figure 50: France Latent TB Testing Market, By Value, 2020H-2030F (USD Million & CAGR)
Figure 51: France Latent TB Testing Market Value, By End User, 2023 (USD Million)
Figure 52: France Latent TB Testing Market Share, By Test Type, By Value, 2023 (%)
Figure 53: France Latent TB Testing Market Share, By End User, By Value, 2023 (%)
Figure 54: Rest of Europe Latent TB Testing Market, By Value, 2020H-2030F (USD Million & CAGR)
Figure 55: Rest of Europe Latent TB Testing Market Value, By End User, 2023 (USD Million)
Figure 56: Rest of Europe Latent TB Testing Market Share, By Test Type, By Value, 2023 (%)
Figure 57: Rest of Europe Latent TB Testing Market Share, By End User, By Value, 2023 (%)
Figure 58: Asia-Pacific Latent TB Testing Market Size, By Value, 2020H-2030F (USD Million)
Figure 59: Asia-Pacific Latent TB Testing Market Share, By Test Type, 2023 (%)
Figure 60: Asia-Pacific Latent TB Testing Market, By Tuberculin Skin Test (TST), By Value, 2020H-2030F (USD Million & CAGR)
Figure 61: Asia-Pacific Latent TB Testing Market, By Interferon Gamma Released Assay (IGRA), By Value, 2020H-2030F (USD Million & CAGR)
Figure 62: Asia-Pacific Latent TB Testing Market, By Diagnostic Laboratories, By Value, 2020H-2030F (USD Million & CAGR)
Figure 63: Asia-Pacific Latent TB Testing Market, By Hospitals and Clinics, By Value, 2020H-2030F (USD Million & CAGR)
Figure 64: Asia-Pacific Latent TB Testing Market, By Academic and Research Institute, By Value, 2020H-2030F (USD Million & CAGR)
Figure 65: China Latent TB Testing Market, By Value, 2020H-2030F (USD Million & CAGR)
Figure 66: China Latent TB Testing Market Value, By End User, 2023 (USD Million)
Figure 67: China Latent TB Testing Market Share, By Test Type, By Value, 2023 (%)
Figure 68: China Latent TB Testing Market Share, By End User, By Value, 2023 (%)
Figure 69: Japan Latent TB Testing Market, By Value, 2020H-2030F (USD Million & CAGR)
Figure 70: Japan Latent TB Testing Market Value, By End User, 2023 (USD Million)
Figure 71: Japan Latent TB Testing Market Share, By Test Type, By Value, 2023 (%)
Figure 72: Japan Latent TB Testing Market Share, By End User, By Value, 2023 (%)
Figure 73: India Latent TB Testing Market, By Value, 2020H-2030F (USD Million & CAGR)
Figure 74: India Latent TB Testing Market Value, By End User, 2023 (USD Million)
Figure 75: India Latent TB Testing Market Share, By Test Type, By Value, 2023 (%)
Figure 76: India Latent TB Testing Market Share, By End User, By Value, 2023 (%)
Figure 77: South Korea Latent TB Testing Market, By Value, 2020H-2030F (USD Million & CAGR)
Figure 78: South Korea Latent TB Testing Market Value, By End User, 2023 (USD Million)
Figure 79: South Korea Latent TB Testing Market Share, By Test Type, By Value, 2023 (%)
Figure 80: South Korea Latent TB Testing Market Share, By End User, By Value, 2023 (%)
Figure 81: Australia Latent TB Testing Market, By Value, 2020H-2030F (USD Million & CAGR)
Figure 82: Australia Latent TB Testing Market Value, By End User, 2023 (USD Million)
Figure 83: Australia Latent TB Testing Market Share, By Test Type, By Value, 2023 (%)
Figure 84: Australia Latent TB Testing Market Share, By End User, By Value, 2023 (%)
Figure 85: Rest of Asia-Pacific Latent TB Testing Market, By Value, 2020H-2030F (USD Million & CAGR)
Figure 86: Rest of Asia-Pacific Latent TB Testing Market Value, By End User, 2023 (USD Million)
Figure 87: Rest of Asia-Pacific Latent TB Testing Market Share, By Test Type, By Value, 2023 (%)
Figure 88: Rest of Asia-Pacific Latent TB Testing Market Share, By End User, By Value, 2023 (%)
Figure 89: Middle East and Africa Latent TB Testing Market Size, By Value, 2020H-2030F (USD Million)
Figure 90: Middle East and Africa Latent TB Testing Market Share, By Test Type, 2023 (%)
Figure 91: Middle East and Africa Latent TB Testing Market, By Tuberculin Skin Test (TST), By Value, 2020H-2030F (USD Million & CAGR)
Figure 92: Middle East and Africa Latent TB Testing Market, By Interferon Gamma Released Assay (IGRA), By Value, 2020H-2030F (USD Million & CAGR)
Figure 93: Middle East and Africa Latent TB Testing Market, By Diagnostic Laboratories, By Value, 2020H-2030F (USD Million & CAGR)
Figure 94: Middle East and Africa Latent TB Testing Market, By Hospitals and Clinics, By Value, 2020H-2030F (USD Million & CAGR)
Figure 95: Middle East and Africa Latent TB Testing Market, By Academic and Research Institute, By Value, 2020H-2030F (USD Million & CAGR)
Figure 96: Global Impact of Drivers and Restraints
Figure 97: Market Share of Prominent Companies of Global Latent TB Testing Market, 2023 (%)
Figure 98: Qiagen Revenues, 2021-2023 (USD Million)
Figure 99: Qiagen Revenue, By Business Segments, 2023 (%)
Figure 100: Qiagen Revenue, By Geographical Segments, 2023 (%)
Figure 101: Sanofi Revenues, 2020-2022 (USD Billion)
Figure 102: Sanofi Revenues, By Geographic Segments, 2023 (%)
Figure 103: Sanofi Revenue, By Business Segments, 2023 (%)
Figure 104: Abbott Laboratories Revenues, 2021-2023 (USD Billion)
Figure 105: Abbott Laboratories Revenues, By Geographic Segments, 2023 (%)
Figure 106: Abbott Laboratories Revenues, By Business Segments, 2023 (%)
Figure 107: Roche Revenues, 2021-2023 (USD Billion)
Figure 108: Roche Revenue, By Business Segment, 2023 (%)
Figure 109: Bio-Rad Laboratories Revenues, 2021-2023 (USD Million)
Figure 110: Bio-Rad Laboratories Revenue, By Business segment, 2023 (%)
Figure 111: Bio-Rad Laboratories, By Geographic Segments, 2023 (%)
Figure 112: BioMerieux Revenues, 2021-2023 (USD Million)
Figure 113: BioMerieux Revenue By Business Segments, 2023 (%)
Figure 114: BioMerieux Revenue, By Geographical Segments, 2023 (%)
Figure 115: Becton Dickinson and Co Revenues, 2022-2024 (USD Million)
Figure 116: Becton Dickinson and Co Revenue, By Business Segments, 2024 (%)
Figure 117: Becton Dickinson and Co Revenue, By Geographical Segments, 2024 (%)
List of Tables
Table A1: Global Impact of Macro Economic Factors, By Region
Table A2: United States Latent TB Testing Market, By Test Type, By Value, 2020-2023 (USD Million)
Table A3: United States Latent TB Testing Market, By Test Type, By Value, 2024-2030 (USD Million)
Table A4: United States Latent TB Testing Market, By End User, By Value, 2020-2023 (USD Million)
Table A5: United States Latent TB Testing Market, By End User, By Value, 2024-2030 (USD Million)
Table A6: Canada Latent TB Testing Market, By Test Type, By Value, 2020-2023 (USD Million)
Table A7: Canada Latent TB Testing Market, By Test Type, By Value, 2024-2030 (USD Million)
Table A8: Canada Latent TB Testing Market, By End User, By Value, 2020-2023 (USD Million)
Table A9: Canada Latent TB Testing Market, By End User, By Value, 2024-2030 (USD Million)
Table A10: Rest of Americas Latent TB Testing Market, By Test Type, By Value, 2020-2023 (USD Million)
Table A11: Rest of Americas Latent TB Testing Market, By Test Type, By Value, 2024-2030 (USD Million)
Table A12: Rest of Americas Latent TB Testing Market, By End User, By Value, 2020-2023 (USD Million)
Table A13: Rest of Americas Latent TB Testing Market, By End User, By Value, 2024-2030 (USD Million)
Table A14: Germany Latent TB Testing Market, By Test Type, By Value, 2020-2023 (USD Million)
Table A15: Germany Latent TB Testing Market, By Test Type, By Value, 2024-2030 (USD Million)
Table A16: Germany Latent TB Testing Market, By End User, By Value, 2020-2023 (USD Million)
Table A17: Germany Latent TB Testing Market, By End User, By Value, 2024-2030 (USD Million)
Table A18: United Kingdom Latent TB Testing Market, By Test Type, By Value, 2020-2023 (USD Million)
Table A19: United Kingdom Latent TB Testing Market, By Test Type, By Value, 2024-2030 (USD Million)
Table A20: United Kingdom Latent TB Testing Market, By End User, By Value, 2020-2023 (USD Million)
Table A21: United Kingdom Latent TB Testing Market, By End User, By Value, 2024-2030 (USD Million)
Table A22: France Latent TB Testing Market, By Test Type, By Value, 2020-2023 (USD Million)
Table A23: France Latent TB Testing Market, By Test Type, By Value, 2024-2030 (USD Million)
Table A24: France Latent TB Testing Market, By End User, By Value, 2020-2023 (USD Million)
Table A25: France Latent TB Testing Market, By End User, By Value, 2024-2030 (USD Million)
Table A26: Rest of Europe Latent TB Testing Market, By Test Type, By Value, 2020-2023 (USD Million)
Table A27: Rest of Europe Latent TB Testing Market, By Test Type, By Value, 2024-2030 (USD Million)
Table A28: Rest of Europe Latent TB Testing Market, By End User, By Value, 2020-2023 (USD Million)
Table A29: Rest of Europe Latent TB Testing Market, By End User, By Value, 2024-2030 (USD Million)
Table A30: China Latent TB Testing Market, By Test Type, By Value, 2020-2023 (USD Million)
Table A31: China Latent TB Testing Market, By Test Type, By Value, 2024-2030 (USD Million)
Table A32: China Latent TB Testing Market, By End User, By Value, 2020-2023 (USD Million)
Table A33: China Latent TB Testing Market, By End User, By Value, 2024-2030 (USD Million)
Table A34: Japan Latent TB Testing Market, By Test Type, By Value, 2020-2023 (USD Million)
Table A35: Japan Latent TB Testing Market, By Test Type, By Value, 2024-2030 (USD Million)
Table A36: Japan Latent TB Testing Market, By End User, By Value, 2020-2023 (USD Million)
Table A37: Japan Latent TB Testing Market, By End User, By Value, 2024-2030 (USD Million)
Table A38: India Latent TB Testing Market, By Test Type, By Value, 2020-2023 (USD Million)
Table A39: India Latent TB Testing Market, By Test Type, By Value, 2024-2030 (USD Million)
Table A40: India Latent TB Testing Market, By End User, By Value, 2020-2023 (USD Million)
Table A41: India Latent TB Testing Market, By End User, By Value, 2024-2030 (USD Million)
Table A42: South Korea Latent TB Testing Market, By Test Type, By Value, 2020-2023 (USD Million)
Table A43: South Korea Latent TB Testing Market, By Test Type, By Value, 2024-2030 (USD Million)
Table A44: South Korea Latent TB Testing Market, By End User, By Value, 2020-2023 (USD Million)
Table A45: South Korea Latent TB Testing Market, By End User, By Value, 2024-2030 (USD Million)
Table A46: Australia Latent TB Testing Market, By Test Type, By Value, 2020-2023 (USD Million)
Table A47: Australia Latent TB Testing Market, By Test Type, By Value, 2024-2030 (USD Million)
Table A48: Australia Latent TB Testing Market, By End User, By Value, 2020-2023 (USD Million)
Table A49: Australia Latent TB Testing Market, By End User, By Value, 2024-2030 (USD Million)
Table A50: Rest of Asia-Pacific Latent TB Testing Market, By Test Type, By Value, 2020-2023 (USD Million)
Table A51: Rest of Asia-Pacific Latent TB Testing Market, By Test Type, By Value, 2024-2030 (USD Million)
Table A52: Rest of Asia-Pacific Latent TB Testing Market, By End User Industry, By Value, 2020-2023 (USD Million)
Table A53: Rest of Asia-Pacific Latent TB Testing Market, By End User Industry, By Value, 2024-2030 (USD Million)
Table A54: Qiagen Key Company Financials, 2021-2023
Table A55: Sanofi Key Financials, 2021-2023
Table A56: Abbott Laboratories Key Financials, 2021-2023
Table A57: Roche Key Financials, 2021-2023
Table A58: Bio-Rad Laboratories Key Company Financials, 2021-2023
Table A59: BioMerieux Key Company Financials, 2021-2023
Table A60: Becton Dickinson Key Company Financials, 2022-2024

Companies Mentioned

  • QIAGEN
  • Sanofi
  • Abbott Laboratories
  • F. Hoffmann-La Roche AG
  • Bio-Rad Laboratories
  • BioMerieux
  • Becton Dickinson and Co
  • Serum Institute of India
  • PerkinElmer Inc.
  • LIONEX GmbH

Related Topics

Related Reports

Latent TB Testing Market by Test Type (Tuberculin Skin Test/TST, IGRA Test), Application (Household Contacts (HHC) of Tuberculosis (TB) Patients, People Living With HIV), End User (Diagnostic Labs, Hospitals), Region - Global Forecast to 2029 - Product Image

Latent TB Testing Market by Test Type (Tuberculin Skin Test/TST, IGRA Test), Application (Household Contacts (HHC) of Tuberculosis (TB) Patients, People Living With HIV), End User (Diagnostic Labs, Hospitals), Region - Global Forecast to 2029

  • Report
  • 261 Pages
  • Global
From
Latent TB Diagnostics Market 2025-2029 - Global Market Analysis and Forecasts by Assay, Risk Factor, and Lab/Place, with Executive and Consultant Guides - Product Image

Latent TB Diagnostics Market 2025-2029 - Global Market Analysis and Forecasts by Assay, Risk Factor, and Lab/Place, with Executive and Consultant Guides

  • Report
  • 322 Pages
  • Global
From
Latent Tuberculosis Infection Detection Market Size, Share & Trends Analysis Report by Brand (QFT-Plus), Test Type, Application, End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Latent Tuberculosis Infection Detection Market Size, Share & Trends Analysis Report by Brand (QFT-Plus), Test Type, Application, End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 125 Pages
  • Global
From
Tuberculosis Diagnostics Market Size, Share & Trends Analysis Report By End Use (Diagnostic Laboratories, Hospitals & Clinics, and Others), By Type, By Regional Outlook and Forecast, 2024 - 2031 - Product Image

Tuberculosis Diagnostics Market Size, Share & Trends Analysis Report By End Use (Diagnostic Laboratories, Hospitals & Clinics, and Others), By Type, By Regional Outlook and Forecast, 2024 - 2031

  • Report
  • 226 Pages
  • Global
From
Tuberculosis Testing Market by Test, Indication, Testing Location, End User - Global Forecast 2025-2030 - Product Image

Tuberculosis Testing Market by Test, Indication, Testing Location, End User - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.